SpringWorks Therapeutics Inc (SWTX) — Long-term Investment Intensity
SpringWorks Therapeutics Inc (SWTX) has a Long-term Investment Intensity of 18.8% as of March 2025. Long-term investments of $94.78 Million represent 18.8% of total assets of $505.36 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check SWTX cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
SpringWorks Therapeutics Inc Long-term Investment Intensity (2019–2024)
This chart shows how SpringWorks Therapeutics Inc's Long-term Investment Intensity has evolved across 6 annual periods from 2019 to 2024. As of March 2025, the intensity stands at 18.8%, reflecting long-term investments of $94.78 Million against total assets of $505.36 Million USD. Explore cash flow to debt ratio of SpringWorks Therapeutics Inc to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for SpringWorks Therapeutics Inc (2019–2024)
The table below presents the year-by-year Long-term Investment Intensity for SpringWorks Therapeutics Inc from 2019 to 2024, covering 6 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see SpringWorks Therapeutics Inc (SWTX) market capitalisation.
| Year | LT Investment Intensity | LT Investments (USD) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2024 | 26.9% | $158.12 Million | $587.28 Million | ▲ +1.4 pp |
| 2023 | 25.5% | $185.34 Million | $725.79 Million | ▲ +24.1 pp |
| 2022 | 1.4% | $8.99 Million | $630.24 Million | ▼ -12.3 pp |
| 2021 | 13.7% | $62.11 Million | $452.49 Million | ▲ +3.8 pp |
| 2020 | 9.9% | $57.21 Million | $576.19 Million | ▲ +9.6 pp |
| 2019 | 0.3% | $976.00K | $334.83 Million | — |